This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

Vision recovery similar at 30 days, consistent with other recent randomized studies ...

The Zoom 4S catheter is designed to simplify stroke thrombectomy by reducing device exchanges.

Recent developments of interest in cardiovascular medicine ...

Longer door-in-door-out times are associated with adverse therapy and complication outcomes for patients with acute ischemic stroke.

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

A Pivotal Step in Optimizing the ADAPT 2.0 Technique for Speed and Simplicity with a Single System Setup CAMPBELL, Calif.--(BUSINESS WIRE)--January 28, 2026-- Imperative Care, Inc. today announced the ...

Neuroprotection in ischaemic stroke commonly means a treatment that results in the preservation of brain tissue in the setting of either focal or global ischaemia. The nominal focus on neuronal tissue ...

The urologist suggested removing the kidney to prevent cancer from spreading throughout my body. He also suggested doing ...

Imperative Care announced that it launched the new Zoom 4S thrombectomy catheter, reporting the first patient cases with the device.